Advertisement

Calpain pp 149-160 | Cite as

Identification of Calpain-Activated Protein Functions

  • Maria del Carmen Lafita-Navarro
  • Maralice Conacci-SorrellEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1915)

Abstract

As opposed to proteasome-mediated proteolysis that leads to protein degradation, calpain proteases carry out limited proteolytic cleavages of their substrates. The cleavage of some substrates can produce active fragments that perform functions that are different from those performed by the full-length proteins. Therefore, cleavage by calpains can operate as a posttranslational modification and increase the functional diversity of target proteins. Nevertheless, activation of protein function by calpain cleavage is still an understudied area in molecular biology. Identifying and functionally characterizing by products generated by calpain cleavage could lead to the discovery of biomarkers and the identification of novel drug targets for the treatment of human diseases. This chapter contains a workflow designed to experimentally characterize novel calpain substrates, including identification of potential calpain targets via Western blotting, characterization of calpain cleavage sites, and the study of cellular functions played by such cleaved products. We will employ MYC as an example for these experiments.

Key words

Calpains Cleavage Calcium Protein activation Degradation MYC MYC-nick Post-translational modification 

References

  1. 1.
    Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83(3):731–801.  https://doi.org/10.1152/physrev.00029.2002CrossRefPubMedGoogle Scholar
  2. 2.
    Ono Y, Sorimachi H (2012) Calpains: an elaborate proteolytic system. Biochim Biophys Acta 1824(1):224–236.  https://doi.org/10.1016/j.bbapap.2011.08.005CrossRefPubMedGoogle Scholar
  3. 3.
    Xu W, Wong TP, Chery N, Gaertner T, Wang YT, Baudry M (2007) Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity. Neuron 53(3):399–412.  https://doi.org/10.1016/j.neuron.2006.12.020CrossRefPubMedGoogle Scholar
  4. 4.
    Abe K, Takeichi M (2007) NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression. Neuron 53(3):387–397.  https://doi.org/10.1016/j.neuron.2007.01.016CrossRefPubMedGoogle Scholar
  5. 5.
    Vennstrom B, Sheiness D, Zabielski J, Bishop JM (1982) Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J Virol 42(3):773–779PubMedPubMedCentralGoogle Scholar
  6. 6.
    Conacci-Sorrell M, Ngouenet C, Eisenman RN (2010) Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiation. Cell 142(3):480–493.  https://doi.org/10.1016/j.cell.2010.06.037CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Eisenman RN (2000) The max network: coordinated transcriptional regulation of cell growth and proliferation. Harvey Lect 96:1–32PubMedGoogle Scholar
  8. 8.
    Conacci-Sorrell M, Ngouenet C, Anderson S, Brabletz T, Eisenman RN (2014) Stress-induced cleavage of Myc promotes cancer cell survival. Genes Dev 28(7):689–707.  https://doi.org/10.1101/gad.231894.113CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Anderson S, Poudel KR, Roh-Johnson M, Brabletz T, Yu M, Borenstein-Auerbach N, Grady WN, Bai J, Moens CB, Eisenman RN, Conacci-Sorrell M (2016) MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation. Proc Natl Acad Sci U S A 113(37):E5481–E5490.  https://doi.org/10.1073/pnas.1610994113CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Branca D (2004) Calpain-related diseases. Biochem Biophys Res Commun 322(4):1098–1104.  https://doi.org/10.1016/j.bbrc.2004.07.126CrossRefPubMedGoogle Scholar
  11. 11.
    Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26(2):163–175.  https://doi.org/10.1038/79876CrossRefPubMedGoogle Scholar
  12. 12.
    Ono Y, Saido TC, Sorimachi H (2016) Calpain research for drug discovery: challenges and potential. Nat Rev Drug Discov 15(12):854–876.  https://doi.org/10.1038/nrd.2016.212CrossRefPubMedGoogle Scholar
  13. 13.
    Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilagyi A, Banoczi Z, Hudecz F, Friedrich P (2004) On the sequential determinants of calpain cleavage. J Biol Chem 279(20):20775–20785.  https://doi.org/10.1074/jbc.M313873200CrossRefPubMedGoogle Scholar
  14. 14.
    Lynch DR, Gleichman AJ (2007) Picking up the pieces: the roles of functional remnants of calpain-mediated proteolysis. Neuron 53(3):317–319.  https://doi.org/10.1016/j.neuron.2007.01.014CrossRefPubMedGoogle Scholar
  15. 15.
    Collins GA, Goldberg AL (2017) The logic of the 26S proteasome. Cell 169(5):792–806.  https://doi.org/10.1016/j.cell.2017.04.023CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Lee DH, Goldberg AL (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8(10):397–403CrossRefGoogle Scholar
  17. 17.
    Mumford RA, Pickett CB, Zimmerman M, Strauss AW (1981) Protease activities present in wheat germ and rabbit reticulocyte lysates. Biochem Biophys Res Commun 103(2):565–572CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Maria del Carmen Lafita-Navarro
    • 1
    • 2
  • Maralice Conacci-Sorrell
    • 1
    • 2
  1. 1.Department of Cell BiologyUniversity of Texas Southwestern Medical CenterDallasUSA
  2. 2.Harold C. Simmons Comprehensive Cancer CenterUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations